Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156583 · ClinicalTrials.gov registry record
Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 20
- Enrollment target
NCT02156583: Completed study, sponsored by Thomas Jefferson University.
NCT02156583 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02156583 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is an observational study evaluating changes in frailty and associated impairments in older heart failure patients receiving left ventricular assist device therapy.
Primary Outcome
Frailty will be assess based on the domains initially described by Fried and colleagues: weakness, low physical activity, unintentional weight loss, slowness and exhaustion. Additional frailty measures include the Short Physical Performance Battery (SPPB), as well as gait speed and hand grip strength as single item measures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-07 |
What the finished NCT02156583 record still lists
NCT02156583 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02156583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02156583 about?
NCT02156583 is a clinical study titled "Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients". This is an observational study evaluating changes in frailty and associated impairments in older heart failure patients receiving left ventricular assist device therapy.
What is the current status of trial NCT02156583?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2014-05. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT02156583?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia